What is the recommended evaluation and treatment, including sleep hygiene measures, for an adult with insomnia?

Adult Insomnia: Evaluation and Treatment

Cognitive behavioral therapy for insomnia (CBT-I) should be the initial treatment for all adults with chronic insomnia, and sleep hygiene alone is insufficient as a standalone treatment. 1, 2

Evaluation Approach

Initial Assessment Components

Conduct a structured clinical interview focusing on:

• Sleep history: Difficulty initiating sleep (sleep onset latency), maintaining sleep (wake after sleep onset), or early morning awakening
• Daytime consequences: Fatigue, cognitive impairment, mood changes, functional impairment
• Duration and frequency: Chronic insomnia requires symptoms ≥3 nights/week for ≥3 months
• Medical history: Screen for conditions causing secondary insomnia (pain, respiratory disorders, endocrine disorders)
• Psychiatric screening: Depression, anxiety, and substance abuse are critical comorbidities 2
• Medication review: Include prescription, over-the-counter, and herbal medications that may disrupt sleep 2

Diagnostic Tools

• Sleep diaries: Collect for 1-2 weeks before and during treatment to track patterns 2
• Validated questionnaires: Insomnia Severity Index (ISI) or Pittsburgh Sleep Quality Index (PSQI) for severity assessment 1
• Actigraphy: Not recommended routinely but may help with differential diagnosis 3
• Polysomnography: Reserve for suspected comorbid sleep disorders (sleep apnea, periodic limb movements, parasomnias) or treatment-resistant insomnia 3, 2

Differential Diagnosis

Rule out these specific conditions before diagnosing primary insomnia:

• Sleep-related breathing disorders (obstructive sleep apnea)
• Circadian rhythm disorders
• Restless legs syndrome/periodic limb movement disorder
• Medication or substance-induced insomnia
• Medical conditions causing insomnia (chronic pain, GERD, hyperthyroidism)
• Psychiatric disorders (depression, anxiety, PTSD) 2

Treatment Algorithm

First-Line: Cognitive Behavioral Therapy for Insomnia (CBT-I)

CBT-I is the standard initial treatment for chronic insomnia in adults of all ages, including older adults and those with comorbidities. 1, 2

Core CBT-I Components (typically 4-8 sessions):

1. Stimulus Control Therapy (most effective single component):

• Go to bed only when sleepy
• Get out of bed if unable to sleep within ~20 minutes (avoid clock-watching)
• Use bed/bedroom only for sleep and sex
• Wake at the same time every morning
• No daytime napping 2, 4

2. Sleep Restriction Therapy:

• Initially limit time in bed to match actual sleep duration from sleep diary
• Gradually increase time in bed by 15-30 minutes when sleep efficiency exceeds 85-90%
• Maintain consistent wake time 4

3. Cognitive Therapy:

• Address dysfunctional beliefs: "I can't sleep without medication," "My life will be ruined if I can't sleep"
• Reduce performance anxiety about sleeping 2, 4

4. Relaxation Training:

• Progressive muscle relaxation
• Diaphragmatic breathing
• Guided imagery 2, 4

Delivery Methods

CBT-I can be delivered effectively through:

• Individual or group therapy
• Digital/web-based platforms
• Telephone-based modules
• Self-help books 1

Sleep Hygiene: Adjunctive Only

Sleep hygiene alone is NOT effective for treating chronic insomnia and must be combined with other therapies. 2

Sleep hygiene recommendations (use as adjunct to CBT-I):

• Maintain consistent sleep-wake schedule
• Avoid caffeine 6+ hours before bed
• Avoid alcohol and nicotine near bedtime
• Limit screen time before bed
• Optimize bedroom environment (dark, quiet, cool temperature)
• Regular exercise (but not within 3-4 hours of bedtime)
• Avoid large meals close to bedtime 2

Second-Line: Pharmacotherapy

Add pharmacotherapy only after CBT-I has been attempted or when CBT-I alone is insufficient, using shared decision-making about benefits, harms, and costs. 1

Medication Sequence for Primary Insomnia:

First choice:

• Short-intermediate acting benzodiazepine receptor agonists (BzRAs): zolpidem, eszopiclone, zaleplon, temazepam
• OR ramelteon (preferred for patients with substance use history or who prefer non-DEA scheduled drugs)
  • Zaleplon/ramelteon: Very short half-life, best for sleep onset only
  • Eszopiclone/temazepam: Longer half-life, better for sleep maintenance 2

Second choice (if first agent unsuccessful):

• Try alternative BzRA or ramelteon 2

Third choice:

• Sedating antidepressants (especially with comorbid depression/anxiety): trazodone, doxepin, amitriptyline, mirtazapine 2

Fourth choice:

• Combined BzRA/ramelteon plus sedating antidepressant 2

Fifth choice (comorbid conditions only):

• Other sedating agents: gabapentin, tiagabine, quetiapine, olanzapine
• Use only when patients may benefit from primary drug action 2

Medications NOT Recommended:

• Over-the-counter antihistamines (diphenhydramine, doxylamine): Lack efficacy and safety data 2
• Herbal supplements (valerian, melatonin): Insufficient evidence 2
• Barbiturates and chloral hydrate: Not recommended 2

Pharmacotherapy Management Principles:

Patient education must cover:

• Treatment goals and realistic expectations
• Safety concerns and side effects
• Drug interactions
• Potential for tolerance and dosage escalation
• Risk of rebound insomnia upon discontinuation
• Availability of CBT-I as alternative 2

Monitoring requirements:

• Follow-up every few weeks initially to assess effectiveness and side effects
• Use lowest effective maintenance dose
• Taper when conditions allow (facilitated by concurrent CBT-I)
• Long-term use acceptable for severe/refractory insomnia with ongoing monitoring 2

Dosing schedules:

• Nightly, intermittent (3 nights/week), or as-needed based on patient needs 2

Combined Therapy (CBT-I + Medication)

Combined therapy shows no consistent advantage over CBT-I alone, but may be appropriate based on:

• Symptom severity and pattern
• Treatment goals and patient preference
• Past treatment responses
• Comorbid conditions
• Cost and availability 2

Ongoing Management

Reassess every few weeks initially, then every 6 months due to high relapse rates. 2

• Continue sleep diary monitoring
• Repeat ISI or PSQI questionnaires
• If treatment fails, consider:
  • Alternative behavioral therapies
  • Different pharmacologic agents
  • Combined therapy
  • Re-evaluation for occult comorbid disorders 2

Common Pitfalls to Avoid

1. Using sleep hygiene as sole treatment: It's ineffective alone and must be combined with CBT-I 2
2. Starting medication without trying CBT-I first: This reverses the evidence-based treatment hierarchy 1
3. Prescribing OTC antihistamines or melatonin: These lack efficacy and safety data for chronic insomnia 2
4. Failing to screen for secondary causes: Medical, psychiatric, and substance-related causes must be identified and treated 2
5. Inadequate follow-up: Regular monitoring is essential for medication safety and effectiveness 2
6. Using long-acting benzodiazepines in older adults: Increased fall and cognitive impairment risk 1